Related references
Note: Only part of the references are listed.The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes
Sho Mokuda et al.
SCIENTIFIC REPORTS (2015)
CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens
Annemieke de Jong et al.
NATURE IMMUNOLOGY (2014)
The origins and functions of dendritic cells and macrophages in the skin
Bernard Malissen et al.
NATURE REVIEWS IMMUNOLOGY (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
IRF8 Mutations and Human Dendritic-Cell Immunodeficiency
Sophie Hambleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
Olga Gorlova et al.
PLOS GENETICS (2011)
Exercise-Induced Pulmonary Hypertension Associated With Systemic Sclerosis Four Distinct Entities
Rajeev Saggar et al.
ARTHRITIS AND RHEUMATISM (2010)
Survivin and IAP proteins in cell-death mechanisms
Dario C. Altieri
BIOCHEMICAL JOURNAL (2010)
Autoantibody Against Survivin in Patients with Systemic Sclerosis
Yuta Koike et al.
JOURNAL OF RHEUMATOLOGY (2010)
CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire
Annemieke de Jong et al.
NATURE IMMUNOLOGY (2010)
The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse
Prafullakumar Tailor et al.
BLOOD (2008)
High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer
Abdolamir Landi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
Lisa C. Zaba et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Scleroderma renal crisis: patient characteristics and long-term outcomes
H. Penn et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2007)
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al.
BLOOD (2006)
Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis
M Bokarewa et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type IIFN-producing plasmacytoid dendritic cells
H Tsujimura et al.
JOURNAL OF IMMUNOLOGY (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
Essential role for ICSBP in the in vivo development of murine CD8 alpha(+) dendritic cells
J Aliberti et al.
BLOOD (2003)
ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8α+ dendritic cells
G Schiavoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation
XC Cao et al.
JOURNAL OF IMMUNOLOGY (2002)
Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis
MK Sharief et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Share Paper
